$KORS Michael Kors Holdings Limited (KORS) 98.27  -0.01

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
$KORS
Michael Kors Holdings Limited (KORS)
98.27  -0.01 (-0.01%)

Past 5 Days
Date Open High Low Last Change % Change Volume
03/10/14 98.41 99.06 97.00 98.27 -0.01 -0.01% 1,413,400
03/07/14 99.16 99.44 98.02 98.28 -0.34 -0.34% 1,368,000
03/06/14 99.30 99.46 98.19 98.62 -0.37 -0.37% 1,279,900
03/05/14 99.03 99.66 97.18 98.99 +0.11 +0.11% 1,557,500
03/04/14 99.00 99.16 97.67 98.88 +0.90 +0.92% 1,952,600

Historical Highs and Lows
-- Period -- -- High -- -- Low -- -- Percent Change --
5-Day 99.66 on 03/05/14     97.00 on 03/10/14     +0.30% since 03/03/14    
1-Month 101.04 on 02/25/14     94.88 on 02/11/14     +2.84% since 02/10/14    
3-Month 101.04 on 02/25/14     74.11 on 01/16/14     +20.12% since 12/10/13    
6-Month 101.04 on 02/25/14     70.59 on 10/09/13     +34.23% since 09/10/13    
12-Month 101.04 on 02/25/14     51.63 on 04/22/13     +68.88% since 03/08/13    
Year to Date 101.04 on 02/25/14     74.11 on 01/16/14     +21.04% since 12/31/13    

New Highs and Lows
For The Last Made New High Percent From Made New Low Percent From
5-Day 2 times -1.39% 3 times +1.31%
1-Month 5 times -2.74% 1 time +3.57%
3-Month 13 times -2.74% 5 times +32.60%
6-Month 22 times -2.74% 5 times +39.21%
12-Month 42 times -2.74% 8 times +90.34%
Year to Date 10 times -2.74% 4 times +32.60%
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Ipsen's Kayfanda® Receives EU Approval for Alagille Syndrome Treatment

Updated Category News Views 67

Kayfanda® Receives Approval for Treatment in the EU Ipsen has made a noteworthy advancement in pediatric healthcare with the recent authorization of Kayfanda® (odevixibat) in the European Union (EU). This innovative treatment specifically addresses cholestatic pruritus, a painful symptom linked to Alagille Syndrome, a rare liver disorder that affects children. This...

Continue Reading
Discover the Remarkable Returns of Vulcan Materials Stock

Updated Category News Views 144

Unveiling Vulcan Materials Company Stock Performance Vulcan Materials Co. (NYSE: VMC) has been a noteworthy performer in the stock market over the past 15 years, surpassing market expectations with a commendable annual return of 15.1%. This stock has consistently outperformed the market, achieving an admirable 2.86% advantage annually. With a current market capitalization...

Continue Reading
AeroPress Launches Premium Coffee Press with Elegant Design

Updated Category News Views 332

AeroPress introduced its Premium coffee press back in 2024, and you can bet the market was watching closely. With a retail price of $149.95, this isn’t just another brewing tool; it’s a statement piece designed for those who take their morning ritual seriously. Traders buzzed about how this could impact sales in a saturated market where every new gadget fights for...

Continue Reading
Investigation Update: Walgreens Boots Alliance Class Action Lawsuit

Updated Category News Views 327

Overview of the Walgreens Boots Alliance Class Action Levi & Korsinsky, LLP has raised awareness among investors regarding a class action securities lawsuit involving Walgreens Boots Alliance, Inc. This company, known for its extensive pharmaceutical and retail operations, is currently facing legal challenges that could significantly impact its investors. Class Definition...

Continue Reading
Savillex Strengthens Market Position with New Acquisition

Updated Category News Views 38

Savillex Acquires Optimum Processing to Enhance Offerings Thompson Street Capital Partners (TSCP) is proud to announce that its portfolio company, Savillex, has completed the acquisition of Optimum Processing, Inc. This strategic move is expected to elevate Savillex's position in the marketplace by combining its innovative fluid handling solutions with Optimum...

Continue Reading